New stem cell transplant method aims to reduce Graft-Versus-Host disease
NCT ID NCT02323867
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 15 times
Summary
This study tests a stem cell transplant for people with blood cancers like leukemia and lymphoma. Doctors remove certain immune cells from donor stem cells to help the body accept the transplant and lower the risk of serious side effects. The goal is to improve survival and reduce complications like graft-versus-host disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19103, United States
Conditions
Explore the condition pages connected to this study.